Abstract
Aim
To translate the Xerostomia Quality-of-Life Scale (XeQoLS) into Italian language (XeQoLS-IT). Xerostomia is the most relevant acute and late toxicity in patients with head and neck cancer treated with radiotherapy (RT). Patient-reported outcome (PRO) instruments are subjective report on patient perception of health status. The XeQoLS consists of 15 items and measures the impact of salivary gland dysfunction and xerostomia on the four major domains of oral health-related QoL.
Methods
The XeQoLS-IT was created through a linguistic validation multi-step process: forward translation (TF), backward translation (TB) and administration of the questionnaire to 35 Italian patients with head and neck cancer. Translation was independently carried out by two radiation oncologists who were Italian native speakers. The two versions were compared and adapted to obtain a reconciled version, version 1 (V1). V1 was translated back into English by an Italian pro skilled in teaching English. After review of discrepancies and choice of the most appropriate wording for clarity and similarity to the original, version 2 (V2) was reached by consensus. To evaluate version 2, patients completed the XeQoLS-IT questionnaire and also underwent a cognitive debriefing.
Results
The questionnaire was considered simple by the patients. The clarity of the instructions and the easiness to answer questions had a mean value of 4.5 (± 0.71) on a scale from 1 to 5.
Conclusion
A valid multi-step process led to the creation of the final version of the XeQoLS-IT, a suitable instrument for the perception of xerostomia in patients treated with RT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E et al (2006) Cancer statistics. CA Cancer J Clin 56:106–130
Henson BS, Inglehart MR, Einsbruch A, Ship JA (2000) Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 37:84–93
Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer. Published online 31 October 2006 in Wiley Interscience (http://www.interscience.wiley.com)
Franzen L, Funegard U, Ericson T, Henriksson R (1992) Parotid gland function during and following radiotherapy of malignancies in the head and neck: a consecutive study of salivary flow and patient discomfort. Eur J Cancer 28:457–462
Eneroth C, Henrikson C, Jacobs P (1972) Effect of fractionated radiotherapy on salivary gland function. Cancer 30:1147–1153
Roesink J, Moerland M, Batterman J et al (2001) Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 51:938–946
Hamlet S, Faull J, Klein B et al (1997) Mastication and swallowing in patients with post-irradiation xerostomia. Int J Radiat Oncol Biol Phys 37:789–796
Logemann J, Pauloski B, Rademaker A et al (2003) Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake and diet after chemoradiation. Head Neck 25:432–437
Pellegrino A, Groff E, Bastiani L, Fattori B, Sotti G (2015) Assessment of radiation-induced xerostomia: validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients. Support Care Cancer 23:925–932
Wong RKW, Deshmukh S, Wyatt G et al (2014) Acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating radiation-induced xerostomia: results of RTOG 0537 phase III study. Int J Radiat Oncol Biol Phys 92:220–227
Koller M, Aaronson NK, Blazeby J et al (2007) Translation procedures for standardised quality of life questionnaire: the European Organisation for Research and Treatment of Cancer (EORTC) approach (2007). Eur J Cancer 43:1810–1820
Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334
Fletcher A, Gore S, Jones D et al (1992) Quality of life measures in health care. II: design, analysis, and interpretation. BMJ 305:1145–1148
George D, Mallery P (2003) SPSS for Windows step by step: A simple guide and reference. 11.0 update, 4th edn. Allyn & Bacon, Boston
Jellema AP, Slotman BJ, Doornaert P et al (2007) Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69(3):751–760
Braam PM, Roesink JM, Moerland MA et al (2005) Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62(3):659–664
Reeve BB, Cai J, Zhang H et al (2016) Factors that impact health related quality of life over time for individuals with head and neck cancer. Laryngoscope 126(12):2718–2725
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare that they have no conflict of interest. This study was conducted in accordance with the Declaration of Helsinki.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lastrucci, L., Bertocci, S., Bini, V. et al. Xerostomia Quality of Life Scale (XeQoLS) questionnaire: validation of Italian version in head and neck cancer patients. Radiol med 123, 44–47 (2018). https://doi.org/10.1007/s11547-017-0798-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-017-0798-7